China's new coronavirus hospital taking first patients

Hospital was built in 10 days


The first patients are being treated at a 1,000-bed hospital that was built in 10 days in China to deal with the coronavirus, according to an article on The Washington Times website.

Huoshenshan Hospital in Wuhan and a second 1,500-bed facility due to open this week were built by construction crews working around the clock.

The Wuhan healthcare facilities mark the second time China has built specialized hospitals in a matter of days. 

As severe acute respiratory syndrome (SARS) spread in 2003, a facility in Beijing was constructed in a week.

Read the article.



February 7, 2020


Topic Area: Infection Control


Recent Posts

Wanted: Scientific Standard for Hospital Cleaning

No accepted criteria exist for defining a surface as clean using microbiologic methods.


NLCS Strengthens Safety and Compliance with Comprehensive Electrical Program

Case study: A renewed partnership with Siemens helps the senior living provider meet NFPA 70B standards, reduce risk, and enhance reliability across its communities.


Sun Valley Surgery Center Suffers a Data Breach

On September 3, 2025, SVSC became aware of a potential issue involving SVSC’s information systems.


EV Charging Stations: Planning for Safety, Convenience, Expansion

Managers need to ensure patient access, coordinate with clinical operations and ensure every phase of construction supports the facility's mission.


Why Ambulatory Surgery Centers Are Turning to Dedicated HVAC Systems

Design experts from Neenan Archistruction explain how single-unit HVAC systems for each operating room enhance infection control, comfort, and resiliency.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.